Sorry, you need to enable JavaScript to visit this website.

This site is intended only for healthcare professionals resident in the United Kingdom

Appropriate management of cSSTI and CAP infections

This promotional meeting is organised and funded by Pfizer and may include reference to Pfizer medicines relevant to agenda topics.

  • Bacterial Topic

Appropriate management of cSSTI and CAP infections

Date: 17th November & 19th November 

Time: 12pm - 17th November 
            6pm - 19th November

Duration: 1 hour 

Additional details: This is a live webinar.  A live Q&A with Dr Silvia Corcione will be available.

Register Here

About the webinar

This webinar is a promotional meeting that will focus on: 
•    Sharing patient case studies in the management of Gram-negative and Gram-positive infections in cSSTI, CAP and paediatrics
•    The role of Zinforo (ceftaroline fosamil) in managing these infections 

About the speaker

Dr Silvia Corcione, 
MD Infectious Diseases, 
Medical Sciences, Infectious Diseases, University of Turin

This meeting is organised & funded by Pfizer Ltd. Please note that, under the law and the ABPI Code of Practice, Pfizer may only promote its medicines and provide hospitality to members of the healthcare professions and other relevant decision makers. Therefore, no unqualified person (e.g. medical students, non-medical spouses/partners/family members) may be invited to or attend Pfizer promotional meetings.


Prescribing information 

Zinforo (ceftaroline fosamil)
Zinforo® 600 mg powder for concentrate for solution for infusion - SPC
Legal category: POM. Basic NHS cost: 10 vial pack £375.00